CH EPL (R5)
1.0.1 - trial-use Switzerland flag

CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: 66231001

identifier: Marketing Authorisation Number/66231001

subject: PackagedProductDefinition: identifier = http://fhir.ch/ig/ch-epl/sid/pcid#Clinical Product Identifier#CH-01003060-0662310010000-0001; containedItemQuantity = 1 Vial; description = KEYTRUDA Inf Konz 100 mg/4ml Durchstf

type: Marketing Authorisation

region: Switzerland

status: valid

statusDate: 2022-02-17

holder: Organization MSD Merck Sharp & Dohme AG

regulator: Organization Swissmedic Swiss Agency for Therapeutic Products

Generated Narrative: Organization #holder-MSD-Merck-Sharp-Dohme-AG

Profile: Organization

identifier: https://www.swissmedic.ch/fhir/identifier/locations/01003060, LOC Identifier/100080484, GLN Identifier/7601001001138

name: MSD Merck Sharp & Dohme AG

Generated Narrative: Organization #regulator-SMC

Profile: Organization

identifier: LOC Identifier/100010911, GLN Identifier/7601001398511

name: Swissmedic Swiss Agency for Therapeutic Products